In the BioHarmony Drug Report Database

"Preview" Icon

Clidinium

Quarzan, Rolufta, Rolufta Ellipta (clidinium) is a small molecule pharmaceutical. Clidinium was first approved as Quarzan on 1982-01-01. It is used to treat inflammatory bowel diseases and peptic ulcer in the USA. It has been approved in Europe to treat chronic obstructive pulmonary disease. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2.

 

Trade Name

 

Rolufta, Rolufta Ellipta
 

Common Name

 

clidinium
 

ChEMBL ID

 

CHEMBL620
 

Indication

 

chronic obstructive pulmonary disease, inflammatory bowel diseases, peptic ulcer
 

Drug Class

 

Quaternary ammonium derivatives

Image (chem structure or protein)

Clidinium structure rendering